SightfileU.S. market data from official filings

Companies › GANX

GAIN THERAPEUTICS INC (GANX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001819411 · EDGAR filings · Updated 2026-07-17

GAIN THERAPEUTICS INC (GANX) has reported institutional ownership of 19.2%, with 42 institutional managers holding positions valued at $15.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
19.2%
Institutional managers
42
Reported 13F value
$15.8M
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GAIN THERAPEUTICS INC has 42 institutional holders and institutional ownership of 19.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-11 (recurring since 2021-05-10) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-01-15 (recurring since 2024-07-12) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Cognition Therapeutics Inc (CGTX) · NEPHROS INC (NEPH) · ELUTIA INC (ELUT) · SENSUS HEALTHCARE INC (SRTS) · Hyperfine Inc (HYPR) · FORTRESS BIOTECH INC (FBIO)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.